MED

Business Context and Reporting Period

Company: Medifast, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2010
Business Overview: Medifast produces, distributes, and sells weight management and disease management products, primarily meal replacements and vitamins. The company operates through three main channels: Take Shape for Life (direct sales via health coaches), Medifast Direct (direct-to-consumer via web/call center), and Medifast Weight Control Centers (brick-and-mortar clinics and franchises).

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 46% year-over-year (YoY) for the quarter and 59% YoY for the nine-month period. This was driven by significant growth across all channels.
• Take Shape for Life: Revenue surged 53% in the quarter and 70% for the nine months, fueled by a 55% increase in active health coaches (approx. 9,000 vs. 5,800 prior year).
• Medifast Direct: Sales increased 30% in the quarter and 38% for the nine months, attributed to improved advertising effectiveness (2.8:1 return on ad spend) and higher call center closing rates.
• Weight Control Centers: Revenue grew 46% in the quarter and 59% for the nine months due to new center openings (32 corporate, 20 franchise) and a 28% increase in same-store sales for established centers.
• Profitability: Net income increased 67% for the quarter and 82% for the nine months. Operating margins improved as fixed manufacturing costs were spread over higher unit volumes.
• Liquidity: Cash and cash equivalents nearly doubled from $10.6 million at year-end 2009 to $20.2 million at September 30, 2010, supported by strong operating cash flows.

Guidance, Outlook, and Risks

• Infrastructure Investment: Management plans to continue investing in infrastructure to support growth, including a new distribution center (opened July 2010), new machinery, and an expanded call center. Plans include opening 6-8 additional corporate clinics in Q4 2010.
• Seasonality: Historically, November/December are slower months, while January/February see increases. However, management notes seasonality has decreased in 2010 due to increased consumer focus on overall health.
• Internal Controls: The company disclosed that disclosure controls and procedures were not effective as of September 30, 2010, due to a material weakness in the tax provision calculation process. Remedial measures (hiring a CPA, external reviews) were implemented in Q2 2010, with management expecting effectiveness by year-end 2010.
• Legal Proceedings: Medifast is prosecuting a civil claim for defamation and conspiracy against Fraud Discovery Institute, Inc., and others.
• Market Risk: The company has limited exposure to market risk, primarily related to variable interest rates on $6.0 million of debt. A 100 basis point increase in LIBOR would impact interest expense by approximately $60,000 annually.

Investor Verification Checklist

• Sustainability of Coach Growth: Verify if the 55% increase in active health coaches is sustainable and monitor churn rates in the Take Shape for Life channel.
• Advertising Efficiency: Confirm the continued 2.8:1 return on advertising spend in the Medifast Direct channel as ad budgets increase.
• Internal Control Remediation: Monitor the Q4 2010 assessment to confirm the material weakness regarding tax provisions has been resolved and controls are deemed effective.
• Inventory Levels: Review inventory turnover given the significant increase in inventory ($17.5M vs $11.2M prior year) to ensure it aligns with sales velocity.
• Legal Outcome: Track the status of the ongoing defamation lawsuit against Fraud Discovery Institute.